Tong Ren Tang Technologies Co. Ltd. (1666.HK)
- Previous Close
4.750 - Open
4.820 - Bid 4.820 x --
- Ask 4.830 x --
- Day's Range
4.800 - 4.860 - 52 Week Range
4.660 - 8.970 - Volume
171,000 - Avg. Volume
1,434,930 - Market Cap (intraday)
6.173B - Beta (5Y Monthly) 1.04
- PE Ratio (TTM)
9.64 - EPS (TTM)
0.500 - Earnings Date Mar 22, 2024
- Forward Dividend & Yield 0.18 (3.70%)
- Ex-Dividend Date Jun 19, 2023
- 1y Target Est
6.69
Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and Hong Kong. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services. In addition, it is involved in the technological development and sale of biological products, Chinese and Western medicines, cosmetics, and healthcare products; wholesale and retail sale of Chinese medicines and healthcare products; and internal and external surgery, medical examination, and hospital management activities. Further, it produces and processes biochemical products; extracts and processes plants; and produces food and daily chemical products, and medical services. Tong Ren Tang Technologies Co. Ltd. was founded in 1669 and is based in Beijing, the People's Republic of China.
www.tongrentangkj.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 1666.HK
Performance Overview: 1666.HK
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1666.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1666.HK
Valuation Measures
Market Cap
6.08B
Enterprise Value
3.26B
Trailing P/E
9.55
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.83
Price/Book (mrq)
0.82
Enterprise Value/Revenue
0.48
Enterprise Value/EBITDA
2.69
Financial Highlights
Profitability and Income Statement
Profit Margin
8.71%
Return on Assets (ttm)
5.37%
Return on Equity (ttm)
10.63%
Revenue (ttm)
6.77B
Net Income Avi to Common (ttm)
590.19M
Diluted EPS (ttm)
0.500
Balance Sheet and Cash Flow
Total Cash (mrq)
4.24B
Total Debt/Equity (mrq)
16.86%
Levered Free Cash Flow (ttm)
--
Research Analysis: 1666.HK
Company Insights: 1666.HK
1666.HK does not have Company Insights